

December 9, 2026 | 5:00-7:00 PM
Ann Arbor
Breakthrough science alone is no longer enough to ensure success. Regulatory uncertainty, shifting policies, capital constraints, and evolving investor expectations are creating new challenges for emerging life science companies.
Join us at BioArbor® on December 9 for a timely fireside conversation featuring Ipsita Smolinski, Managing Director of Capitol Street and faculty member at Georgetown University, moderated by Tony Dace, Vice President – Life Sciences at J.P. Morgan.
Drawing on experience across Wall Street and Washington, the discussion will explore investor priorities, policy shifts, emerging opportunities, and strategies to help life science entrepreneurs navigate an increasingly complex landscape.
REGISTER TODAY |

MichBio is Heading to J.P. Morgan Healthcare Week—Let Us Take You Along |
MichBio will be in San Francisco for J.P. Morgan Healthcare Week, January 11–14, 2027, connecting with industry leaders, investors, and potential partners. Can’t attend? Let MichBio help you make connections.MichBio invites eligible members to leverage our presence at JPM Healthcare Week through pitch deck reviews and partnering meeting support. This opportunity is designed for companies with an active product or technology portfolio, a solid business plan, and an interest in licensing or partnering, particularly those developing therapeutics, diagnostics, or health technologies. Deadline to request partnering support: December 4, 2026, at 5:00 PM ET. |
|

|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|

|
|
|
|
|
|
|
|

|
|















